In a previous study, it was shown that GLP-1 RAs have a cardioprotective effect in ST-elevation myocardial infarction (STEMI) patients with reduced all-cause mortality [18]. This evidence concerns the gene GLP1R and ST Elevation Myocardial Infarction.